Universitätsklinikum Jena

Az itteni vizsgálatok

Miről szól a helyszín 60 vizsgálata, a regiszteri adatlapjaik szerint.

Betegségek

• Koszorúér-betegség5 vizsgálat
• Mieloproliferatív neopláziák5 vizsgálat
• Szívelégtelenség4 vizsgálat
• Colitis ulcerosa3 vizsgálat
• Crohn-betegség3 vizsgálat
• Depresszió3 vizsgálat
• Krónikus vesebetegség3 vizsgálat
• Liver cirrhosis3 vizsgálat
• Bronchiectasis2 vizsgálat
• Gyermekkori daganatok2 vizsgálat
• Gyomor- és nyelőcsőrák2 vizsgálat
• Hólyagrák2 vizsgálat
• és még 25

Fázis

• 3. fázis21 vizsgálat
• 2. fázis11 vizsgálat
• 4. fázis2 vizsgálat
• 1/2. fázis1 vizsgálat
• 2/3. fázis1 vizsgálat

Állapot

• Lezárult22 vizsgálat
• Toboroz16 vizsgálat
• Fut, nem toboroz14 vizsgálat
• Még nem toboroz5 vizsgálat
• Leállították3 vizsgálat

Fő szponzor

• Boehringer Ingelheim5 vizsgálat
• Janssen Research & Development, LLC3 vizsgálat
• Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest2 vizsgálat
• Universitätsklinikum Hamburg-Eppendorf2 vizsgálat
• Abiomed Inc.1 vizsgálat
• és még 47

Futó vizsgálatok

• Még nem toboroz

  A Study to Learn How Well People With Bronchiectasis Tolerate Continued Treatment With Verducatib After Earlier Studies (AIRTIVITY®-ON)

  NCT07915219· 3. fázis· Boehringer Ingelheim· Forrás

  Contact: Boehringer Ingelheim

• Még nem toboroz

  Asciminib Frontline Risk Adapted

  NCT07804901· 2. fázis· Prof. Dr. med. Andreas Hochhaus· Forrás

  Contact: Andreas Hochhaus, Prof. Dr.

• Még nem toboroz

  A Study to Understand How Nerandomilast Works in People With Active Idiopathic Inflammatory Myopathies

  NCT07789015· 3. fázis· Boehringer Ingelheim· Forrás

  Contact: Boehringer Ingelheim

• Toboroz

  Registry for Duchenne and Becker Muscular Dystrophy

  NCT07402122· Dr. Andreas Ziegler· Forrás

  Contact: Ralf Husain, Dr. med.

• Még nem toboroz

  Phase 2 trial of ARPI to AR-degrader (BMS-986365) switch for suboptimal PSA-response in mCSPC (eARly-SWITCH).

  2025-523672-23-00· 2. fázis· UroTrials GmbH· Forrás

• Toboroz

  A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease

  NCT07499232· 3. fázis· Janssen Research & Development, LLC· Forrás

• Toboroz

  Zanidatamab in Combination With Pembrolizumab and Chemotherapy in HER2 and PD-L1 Positive Metastatic Gastroesophageal Adenocarcinoma (GEA) Patients

  NCT07176312· 2. fázis· Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest· Forrás

  Contact: Udo Lindig, Dr.

• Toboroz

  Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer With Disease Progression on or After Immunotherapy

  NCT07106762· 2/3. fázis· Bristol-Myers Squibb· Forrás

  Contact: Marc-Oliver Grimm, Site 0147

• Toboroz

  The AIRTIVITY™ Study: A Study to Find Out Whether BI 1291583 Helps People With Bronchiectasis

  NCT06872892· 3. fázis· Boehringer Ingelheim· Forrás

  Contact: Boehringer Ingelheim

• Toboroz

  A Study to Evaluate the Efficacy, Safety and Tolerability of BMS-986368 in Participants With Multiple Sclerosis Spasticity

  NCT06782490· 2. fázis· Celgene· Forrás

  Contact: Matthias Schwab, Site 0023

• Toboroz

  Safety and Efficacy of Intravenous Thrombolysis in Patients With Ischemic Stroke and Direct Oral Anticoagulants Intake

  NCT06571149· 4. fázis· Insel Gruppe AG, University Hospital Bern· Forrás

• Toboroz

  LEOPARD Training and Validation Data Collection Study

  NCT06675604· Assistance Publique - Hôpitaux de Paris· Forrás

  Contact: Falk Rauchfuss, MD-PHD

• Toboroz

  A Non-interventional, Post-authorisation Safety Study of Patients Treated With Efgartigimod Alfa

  NCT06298565· argenx· Forrás

  Contact: Annekathrin Rödiger, MD

• Toboroz

  A Study to Evaluate TAR-210 Versus Single Agent Intravesical Cancer Treatment in Participants With Bladder Cancer

  NCT06319820· 3. fázis· Janssen Research & Development, LLC· Forrás

• Toboroz

  Personalized Long-term Human Albumin Treatment in Patients With Decompensated Cirrhosis and Ascites

  NCT05056220· 3. fázis· Aleksander Krag· Forrás

  Contact: Alexander Zipprich

• Fut, nem toboroz

  Early Genetic Identification of Obesity

  NCT06239064· Rolfs Consulting und Verwaltungs-GmbH (RCV)· Forrás

• Toboroz

  Prevention Of Sudden Cardiac Death After Myocardial Infarction by Defibrillator Implantation

  NCT05665608· Charite University, Berlin, Germany· Forrás

  Contact: Gerhard Hindricks, Prof

• Toboroz

  CytOSorb TreatMent Of Critically Ill PatientS Registry

  NCT05146336· CytoSorbents, Inc· Forrás

  Contact: Christian Schulze, MD, Prof (principal investigator)

• Fut, nem toboroz

  TRICuspid Intervention in Heart Failure Trial

  NCT04634266· LMU Klinikum· Forrás

• Fut, nem toboroz

  A Study to Test How Safe Pozelimab and Cemdisiran Combination Therapy and Cemdisiran Alone Are and How Well They Work in Adult Patients With Generalized Myasthenia Gravis

  NCT05070858· 3. fázis· Regeneron Pharmaceuticals· Forrás

• Toboroz

  A Comparison of Two Psychotherapy Programs in Persistently Depressed Treatment-Resistant Inpatients

  NCT04996433· University of Greifswald· Forrás

  Contact: Nils Opel, Prof. Dr.

• Fut, nem toboroz

  BIOTRONIK Dynetic-35 Stent for the Treatment of Peripheral Iliac Lesions

  NCT04830228· Biotronik AG· Forrás

• Fut, nem toboroz

  SeQuent® SCB "All Comers" Post Market Clinical Follow-up (PMCF)

  NCT04470934· B. Braun Melsungen AG· Forrás

• Fut, nem toboroz

  Study of Selinexor in Combination With Ruxolitinib in Myelofibrosis

  NCT04562389· 3. fázis· Karyopharm Therapeutics Inc· Forrás

• Fut, nem toboroz

  The Elixir Bioadaptor vs. The Onyx Stent in De Novo Native Coronary Arteries

  NCT04192747· Elixir Medical Corporation· Forrás

• Fut, nem toboroz

  Pulmonary Artery Sensor System Pressure Monitoring to Improve Heart Failure (HF) Outcomes

  NCT04398654· IHF GmbH - Institut für Herzinfarktforschung· Forrás

• Fut, nem toboroz

  Primary Unloading and Delayed Reperfusion in ST-Elevation Myocardial Infarction: The STEMI-DTU Trial

  NCT03947619· Abiomed Inc.· Forrás

• Toboroz

  SIOP RANDOMET 2017

  2023-508926-91-00· 3. fázis· GPOH gGmbH· Forrás

• Toboroz

  High-Risk Neuroblastoma Study 2 of SIOP-Europa-Neuroblastoma (SIOPEN)

  NCT04221035· 3. fázis· Gustave Roussy, Cancer Campus, Grand Paris· Forrás

• Fut, nem toboroz

  Pazopanib Vs. Pazopanib Plus Gemcitabine

  NCT02203760· 2. fázis· North Eastern German Society of Gynaecological Oncology· Forrás

• Fut, nem toboroz

  International Validation Study of Sentinel Node Biopsy in Early Cervical Cancer

  NCT03386734· Centre Hospitalier Universitaire de Besancon· Forrás

• Fut, nem toboroz

  Randomized Trial of TAVI vs. SAVR in Patients With Severe Aortic Valve Stenosis at Low to Intermediate Risk of Mortality

  NCT03112980· Universitätsklinikum Hamburg-Eppendorf· Forrás

• Fut, nem toboroz

  Ruxolitinib vs Allogeneic SCT for Patients With Myelofibrosis According to Donor Availability

  NCT03333187· 2. fázis· Universitätsklinikum Hamburg-Eppendorf· Forrás

• Toboroz

  Clinical AML Registry and Biomaterial Database of the Study Alliance Leukemia (SAL)

  NCT03188874· Technische Universität Dresden· Forrás

  Contact: Ulf Schnetzke, PD Dr.

• Toboroz

  GMALL Registry and Collection of Biomaterial: Prospective Data Collection Regarding Diagnosis, Treatment and Outcome of Adult Acute Lymphoblastic Leukemia (ALL) Patients and Related Diseases Associated With a Prospective Collection of Biomaterial

  NCT02872987· Goethe University· Forrás

  Contact: Nicola Gökbuget, Dr. med.

Egyszerre toboroz

Hány vizsgálat toboroz itt egyszerre ugyanarra az indikációra. Darabszám, nem értékelés.

• Bronchiectasis2 toboroz
• Gyermekkori daganatok2 toboroz
• Liver cirrhosis2 toboroz
• Akut limfoid leukémia (ALL)1 toboroz
• Akut mieloid leukémia (AML)1 toboroz
• Crohn-betegség1 toboroz
• Depresszió1 toboroz
• Dermatomyositis and polymyositis (myositis)1 toboroz
• Duchenne-izomdisztrófia1 toboroz
• Gyomor- és nyelőcsőrák1 toboroz
• Hólyagrák1 toboroz
• Koszorúér-betegség1 toboroz
• Krónikus mieloid leukémia (CML)1 toboroz
• Myasthenia gravis1 toboroz
• Neuroblasztóma1 toboroz
• Primer biliáris cholangitis (PBC)1 toboroz
• Prosztatarák1 toboroz
• Sclerosis multiplex (SM)1 toboroz
• Stroke (szélütés)1 toboroz
• Szívelégtelenség1 toboroz

Lezárt vizsgálatok

• Lezárult

  To Investigate Efficacy, Pharmacodynamics, and Safety of BC 007 in Participants With Long COVID

  NCT05911009· 2. fázis· Berlin Cures GmbH· Forrás

• Lezárult

  A Study in Participants With Major Depressive Disorder (MDD) With Anhedonia and Inadequate Response to Current Antidepressant Therapy Including a Selective Serotonin Reuptake Inhibitor (SSRI) or Serotonin Norepinephrine Reuptake Inhibitor (SNRI)

  NCT05841030· Janssen Research & Development, LLC· Forrás

• Lezárult

  A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Parallel Study to Assess the Efficacy, Safety, Tolerability, PK, and Biomarker Effects of PTC857 in Adult Subjects With Amyotrophic Lateral Sclerosis (CARDINALS)

  NCT05349721· 2. fázis· PTC Therapeutics Inc.· Forrás

• Lezárult

  A Study in People With Pulmonary Fibrosis to Monitor Cough With a Wearable Device

  NCT05670587· Boehringer Ingelheim· Forrás

• Lezárult

  ComparIson of Strategies to PrepAre SeveRely CALCified Coronary Lesions 2

  NCT05072730· Deutsches Herzzentrum Muenchen· Forrás

• Lezárult

  Retrospective Analysis of Performance and Treatment Data Collected for Genius SleddFlux Filter, Ultraflux AV 600 S Filter & Genius 90 Concentrates in Haemodialysis Patients

  NCT05282732· Fresenius Medical Care Deutschland GmbH· Forrás

• Lezárult

  Efficacy and Safety Study of Rimegepant in Episodic Migraine Prevention With Multiple Dosing Regimens

  NCT05217927· 4. fázis· Pfizer· Forrás

• Toboroz

  JNJ-90301900 (NBTXR3) Activated by Radiotherapy With or Without Cetuximab in LA-HNSCC

  NCT04892173· 3. fázis· Johnson & Johnson Enterprise Innovation Inc.· Forrás

• Leállították

  Efficacy and Safety of KBP-5074 in Uncontrolled Hypertension and Moderate or Severe Chronic Kidney Disease (CKD)

  NCT04968184· 3. fázis· Novo Nordisk A/S· Forrás

• Leállították

  Enhancing Ultrasound & Photoacoustic for Recognition of Intestinal Abnormalities

  NCT04456400· iThera Medical GmbH· Forrás

• Leállították

  A Study to Evaluate Efficacy and Safety of Macitentan 75 mg in Inoperable or Persistent/Recurrent Chronic Thromboembolic Pulmonary Hypertension

  NCT04271475· 3. fázis· Actelion· Forrás

• Lezárult

  EMPA-KIDNEY (The Study of Heart and Kidney Protection With Empagliflozin)

  NCT03594110· 3. fázis· Boehringer Ingelheim· Forrás

• Lezárult

  Modified FOLFOX Plus/Minus Nivolumab and Ipilimumab vs. FLOT Plus Nivolumab in Patients With Previously Untreated Advanced or Metastatic Gastric Cancer

  NCT03647969· 2. fázis· Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest· Forrás

• Lezárult

  Randomized, Double-Blind Study to Evaluate Efficacy and Safety of Cenobamate Adjunctive Therapy in PGTC Seizures

  NCT03678753· 3. fázis· SK Life Science, Inc.· Forrás

• Lezárult

  Atezolizumab With Bevacizumab and Chemotherapy vs Bevacizumab and Chemotherapy in Early Relapse Ovarian Cancer

  NCT03353831· 3. fázis· AGO Research GmbH· Forrás

• Lezárult

  Effects of Long-Term Administration of Human Albumin in Participants With Decompensated Cirrhosis and Ascites

  NCT03451292· 3. fázis· Grifols Therapeutics LLC· Forrás

• Lezárult

  A Safety Extension Study of Ontamalimab in Participants With Moderate to Severe Ulcerative Colitis or Crohn's Disease (AIDA)

  NCT03283085· 3. fázis· Shire· Forrás

• Toboroz

  A Study to Assess Effectiveness and Efficiency of VNS Therapy in Patients With Difficult to Treat Depression.

  NCT03320304· LivaNova· Forrás

  Contact: Funda Basdar

• Lezárult

  A Study of Rucaparib Versus Physician's Choice of Therapy in Participants With Metastatic Castration-resistant Prostate Cancer and Homologous Recombination Gene Deficiency

  NCT02975934· 3. fázis· pharmaand GmbH· Forrás

• Lezárult

  A Study to Evaluate the Efficacy and Safety of Pemigatinib (INCB054828) in Subjects With Myeloid/Lymphoid Neoplasms With FGFR1 Rearrangement - (FIGHT-203)

  NCT03011372· 2. fázis· Incyte Corporation· Forrás

• Lezárult

  Filgotinib in Long-Term Extension Study of Adults With Ulcerative Colitis

  NCT02914535· 3. fázis· Alfasigma S.p.A.· Forrás

• Lezárult

  ATALANTE: Atezolizumab vs Placebo Phase III Study in Late Relapse Ovarian Cancer Treated With Chemotherapy+Bevacizumab

  NCT02891824· 3. fázis· ARCAGY/ GINECO GROUP· Forrás

• Lezárult

  Ponatinib in Participants With Resistant Chronic Phase Chronic Myeloid Leukemia (CP-CML) to Characterize the Efficacy and Safety of a Range of Doses

  NCT02467270· 2. fázis· Takeda· Forrás

• Lezárult

  A Clinical Evaluation of the Safety and Effectiveness of the MitraClip System in the Treatment of Clinically Significant Functional Mitral Regurgitation

  NCT02444338· University Medical Center Goettingen· Forrás

• Lezárult

  Ruxolitinib and Pomalidomide Combination Therapy in Patients With Primary and Secondary MF

  NCT01644110· 1/2. fázis· University of Ulm· Forrás